{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:07:52Z","timestamp":1790723272122,"version":"4.1.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM118182"],"award-info":[{"award-number":["R35GM118182"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1GM128008"],"award-info":[{"award-number":["RO1GM128008"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18542-5","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:25:30Z","timestamp":1758885930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The cholinergic drug galantamine ameliorates acute and subacute peripheral and brain manifestations of acute respiratory distress syndrome in mice"],"prefix":"10.1038","volume":"15","author":[{"given":"Aidan","family":"Falvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhoshi P.","family":"Palandira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saher","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling","family":"Tynan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Marciano","family":"Consolim-Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine N.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta S.","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Tracey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin A.","family":"Pavlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"18542_CR1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.2017.21907","volume":"319","author":"E Fan","year":"2018","unstructured":"Fan, E., Brodie, D. & Slutsky, A. S. Acute respiratory distress syndrome: advances in diagnosis and treatment. Jama 319, 698\u2013710. https:\/\/doi.org\/10.1001\/jama.2017.21907 (2018).","journal-title":"Jama"},{"key":"18542_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani, G. et al. Patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. Jama 315, 788\u2013800. https:\/\/doi.org\/10.1001\/jama.2016.0291 (2016).","journal-title":"Jama"},{"key":"18542_CR3","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMoa050333","volume":"353","author":"GD Rubenfeld","year":"2005","unstructured":"Rubenfeld, G. D. et al. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353, 1685\u20131693. https:\/\/doi.org\/10.1056\/NEJMoa050333 (2005).","journal-title":"N. Engl. J. Med."},{"key":"18542_CR4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMoa022450","volume":"348","author":"MS Herridge","year":"2003","unstructured":"Herridge, M. S. et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N. Engl. J. Med. 348, 683\u2013693. https:\/\/doi.org\/10.1056\/NEJMoa022450 (2003).","journal-title":"N. Engl. J. Med."},{"key":"18542_CR5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00134-016-4321-8","volume":"42","author":"MS Herridge","year":"2016","unstructured":"Herridge, M. S. et al. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive Care Med. 42, 725\u2013738. https:\/\/doi.org\/10.1007\/s00134-016-4321-8 (2016).","journal-title":"Intensive Care Med."},{"key":"18542_CR6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s13054-019-2626-z","volume":"23","author":"C Sasannejad","year":"2019","unstructured":"Sasannejad, C., Ely, E. W. & Lahiri, S. Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms. Crit. Care. (London, England). 23, 352. https:\/\/doi.org\/10.1186\/s13054-019-2626-z (2019).","journal-title":"Crit. Care. (London, England)"},{"key":"18542_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1164\/rccm.200406-763OC","volume":"171","author":"RO Hopkins","year":"2005","unstructured":"Hopkins, R. O. et al. Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. Am. J. Respir. Crit Care Med. 171, 340\u2013347. https:\/\/doi.org\/10.1164\/rccm.200406-763OC (2005).","journal-title":"Am. J. Respir. Crit Care Med."},{"key":"18542_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1440-1843.2008.01419.x","volume":"14","author":"ME Mikkelsen","year":"2009","unstructured":"Mikkelsen, M. E. et al. Cognitive, mood and quality of life impairments in a select population of ARDS survivors. Respirol. (Carlton Vic). 14, 76\u201382. https:\/\/doi.org\/10.1111\/j.1440-1843.2008.01419.x (2009).","journal-title":"Respirol. (Carlton Vic)"},{"key":"18542_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00134-017-5009-4","volume":"44","author":"OJ Bienvenu","year":"2018","unstructured":"Bienvenu, O. J. et al. Psychiatric symptoms after acute respiratory distress syndrome: a 5-year longitudinal study. Intensive Care Med. 44, 38\u201347. https:\/\/doi.org\/10.1007\/s00134-017-5009-4 (2018).","journal-title":"Intensive Care Med."},{"key":"18542_CR10","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0140-6736(22)01439-8","volume":"400","author":"EA Gorman","year":"2022","unstructured":"Gorman, E. A., O\u2019Kane, C. M. & McAuley, D. F. Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management. Lancet 400, 1157\u20131170. https:\/\/doi.org\/10.1016\/S0140-6736(22)01439-8 (2022).","journal-title":"Lancet"},{"key":"18542_CR11","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/thoraxjnl-2017-210337","volume":"72","author":"SM Brown","year":"2017","unstructured":"Brown, S. M. et al. Understanding patient outcomes after acute respiratory distress syndrome: identifying subtypes of physical, cognitive and mental health outcomes. Thorax 72, 1094\u20131103 (2017).","journal-title":"Thorax"},{"key":"18542_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jinf.2021.08.018","volume":"83","author":"J Aranda","year":"2021","unstructured":"Aranda, J. et al. Long-term impact of COVID-19 associated acute respiratory distress syndrome. J. Infect. 83, 581\u2013588. https:\/\/doi.org\/10.1016\/j.jinf.2021.08.018 (2021).","journal-title":"J. Infect."},{"key":"18542_CR13","doi-asserted-by":"publisher","first-page":"6554","DOI":"10.1038\/s41598-023-32699-x","volume":"13","author":"JL Sturgill","year":"2023","unstructured":"Sturgill, J. L. et al. Post-intensive care syndrome and pulmonary fibrosis in patients surviving ARDS-pneumonia of COVID-19 and non-COVID-19 etiologies. Sci. Rep. 13, 6554. https:\/\/doi.org\/10.1038\/s41598-023-32699-x (2023).","journal-title":"Sci. Rep."},{"key":"18542_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41479-021-00092-9","volume":"13","author":"A Aslan","year":"2021","unstructured":"Aslan, A., Aslan, C., Zolbanin, N. M. & Jafari, R. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management. Pneumonia 13, 14. https:\/\/doi.org\/10.1186\/s41479-021-00092-9 (2021).","journal-title":"Pneumonia"},{"key":"18542_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13054-024-04810-9","volume":"28","author":"N Latronico","year":"2024","unstructured":"Latronico, N., Eikermann, M., Ely, E. W. & Needham, D. M. Improving management of ARDS: uniting acute management and long-term recovery. Crit. Care. 28, 58. https:\/\/doi.org\/10.1186\/s13054-024-04810-9 (2024).","journal-title":"Crit. Care"},{"key":"18542_CR16","doi-asserted-by":"publisher","unstructured":"Han, S. & Mallampalli, R. K. The acute respiratory distress syndrome: from mechanism to translation. J. Immunol. (Baltimore, Md.) 194, 855\u2013860, (1950). https:\/\/doi.org\/10.4049\/jimmunol.1402513 (2015).","DOI":"10.4049\/jimmunol.1402513"},{"key":"18542_CR17","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1378\/chest.08-2408","volume":"136","author":"GU Meduri","year":"2009","unstructured":"Meduri, G. U., Annane, D., Chrousos, G. P., Marik, P. E. & Sinclair, S. E. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest 136, 1631\u20131643. https:\/\/doi.org\/10.1378\/chest.08-2408 (2009).","journal-title":"Chest"},{"key":"18542_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00423-008-0317-3","volume":"393","author":"K Buttenschoen","year":"2008","unstructured":"Buttenschoen, K. et al. Endotoxemia and endotoxin tolerance in patients with ARDS. Langenbeck\u2019s Archives Surg. 393, 473\u2013478. https:\/\/doi.org\/10.1007\/s00423-008-0317-3 (2008).","journal-title":"Langenbeck\u2019s Archives Surg."},{"key":"18542_CR19","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1378\/chest.107.4.1062","volume":"107","author":"GU Meduri","year":"1995","unstructured":"Meduri, G. U. et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1\u03b2 and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107, 1062\u20131073. https:\/\/doi.org\/10.1378\/chest.107.4.1062 (1995).","journal-title":"Chest"},{"key":"18542_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1164\/ajrccm.154.1.8680703","volume":"154","author":"RP Baughman","year":"1996","unstructured":"Baughman, R. P., Gunther, K. L., Rashkin, M. C., Keeton, D. A. & Pattishall, E. N. Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators. Am. J. Respir. Crit Care Med. 154, 76\u201381 (1996).","journal-title":"Am. J. Respir. Crit Care Med."},{"key":"18542_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.CCM.0000149854.61192.DC","volume":"33","author":"PE Parsons","year":"2005","unstructured":"Parsons, P. E. et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit. Care Med. 33, 1\u20136 (2005).","journal-title":"Crit. Care Med."},{"key":"18542_CR22","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1164\/ajrccm.165.7.2106014","volume":"165","author":"GU Meduri","year":"2002","unstructured":"Meduri, G. U., Tolley, E. A., Chrousos, G. P. & Stentz, F. Prolonged Methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am. J. Respir. Crit Care Med. 165, 983\u2013991 (2002).","journal-title":"Am. J. Respir. Crit Care Med."},{"key":"18542_CR23","doi-asserted-by":"publisher","unstructured":"D\u2019Alessio, F. R. Mouse Models of Acute Lung Injury and ARDS. Methods in molecular biology (Clifton, N.J.) 1809, 341\u2013350, (2018). https:\/\/doi.org\/10.1007\/978-1-4939-8570-8_22","DOI":"10.1007\/978-1-4939-8570-8_22"},{"key":"18542_CR24","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1172\/jci36498","volume":"119","author":"FR D\u2019Alessio","year":"2009","unstructured":"D\u2019Alessio, F. R. et al. CD4\u2009+\u2009CD25\u2009+\u2009Foxp3\u2009+\u2009Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J. Clin. Investig. 119, 2898\u20132913. https:\/\/doi.org\/10.1172\/jci36498 (2009).","journal-title":"J. Clin. Investig."},{"key":"18542_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1165\/rcmb.2014-0327OC","volume":"52","author":"BD Singer","year":"2015","unstructured":"Singer, B. D. et al. Regulatory T cell DNA methyltransferase Inhibition accelerates resolution of lung inflammation. Am. J. Respir. Cell Mol. Biol. 52, 641\u2013652. https:\/\/doi.org\/10.1165\/rcmb.2014-0327OC (2015).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"18542_CR26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bbi.2018.07.013","volume":"73","author":"B Sahu","year":"2018","unstructured":"Sahu, B., Sandhir, R. & Naura, A. S. Two hit induced acute lung injury impairs cognitive function in mice: A potential model to study cross talk between lung and brain. Brain. Behav. Immun. 73, 633\u2013642. https:\/\/doi.org\/10.1016\/j.bbi.2018.07.013 (2018).","journal-title":"Brain. Behav. Immun."},{"key":"18542_CR27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrendo.2012.189","volume":"8","author":"VA Pavlov","year":"2012","unstructured":"Pavlov, V. A. & Tracey, K. J. The vagus nerve and the inflammatory reflex\u2013linking immunity and metabolism. Nat. Rev. Endocrinol. 8, 743\u2013754. https:\/\/doi.org\/10.1038\/nrendo.2012.189 (2012).","journal-title":"Nat. Rev. Endocrinol."},{"key":"18542_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nn.4477","volume":"20","author":"VA Pavlov","year":"2017","unstructured":"Pavlov, V. A. & Tracey, K. J. Neural regulation of immunity: molecular mechanisms and clinical translation. Nat. Neurosci. 20, 156\u2013166. https:\/\/doi.org\/10.1038\/nn.4477 (2017).","journal-title":"Nat. Neurosci."},{"key":"18542_CR29","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1146\/annurev-immunol-042617-053158","volume":"36","author":"VA Pavlov","year":"2018","unstructured":"Pavlov, V. A., Chavan, S. S. & Tracey, K. J. Molecular and functional neuroscience in immunity. Annu. Rev. Immunol. 36, 783\u2013812. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053158 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"18542_CR30","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1016\/j.neuron.2022.09.003","volume":"110","author":"VA Pavlov","year":"2022","unstructured":"Pavlov, V. A. & Tracey, K. J. Bioelectronic medicine: preclinical insights and clinical advances. Neuron 110, 3627\u20133644. https:\/\/doi.org\/10.1016\/j.neuron.2022.09.003 (2022).","journal-title":"Neuron"},{"key":"18542_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxab068","author":"A Falvey","year":"2021","unstructured":"Falvey, A., Metz, C. N., Tracey, K. J. & Pavlov, V. A. Peripheral nerve stimulation and immunity: the expanding opportunities for providing mechanistic insight and therapeutic intervention. Int. Immunol. https:\/\/doi.org\/10.1093\/intimm\/dxab068 (2021).","journal-title":"Int. Immunol."},{"key":"18542_CR32","doi-asserted-by":"publisher","unstructured":"Lehner, K. R. et al. Forebrain cholinergic signaling regulates innate immune responses and inflammation. Front. Immunol. 10 https:\/\/doi.org\/10.3389\/fimmu.2019.00585 (2019).","DOI":"10.3389\/fimmu.2019.00585"},{"key":"18542_CR33","doi-asserted-by":"publisher","first-page":"29803","DOI":"10.1073\/pnas.2008213117","volume":"117","author":"AM Kressel","year":"2020","unstructured":"Kressel, A. M. et al. Identification of a brainstem locus that inhibits tumor necrosis factor. Proc. Natl. Acad. Sci. U.S.A. 117, 29803\u201329810. https:\/\/doi.org\/10.1073\/pnas.2008213117 (2020).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"18542_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2024.04.027","author":"A Falvey","year":"2024","unstructured":"Falvey, A. et al. Electrical stimulation of the dorsal motor nucleus of the vagus in male mice can regulate inflammation without affecting the heart rate. Brain. Behav. Immun. https:\/\/doi.org\/10.1016\/j.bbi.2024.04.027 (2024).","journal-title":"Brain. Behav. Immun."},{"key":"18542_CR35","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nature01321","volume":"420","author":"KJ Tracey","year":"2002","unstructured":"Tracey, K. J. The inflammatory reflex. Nature 420, 853\u2013859. https:\/\/doi.org\/10.1038\/nature01321 (2002).","journal-title":"Nature"},{"key":"18542_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0165-1838(93)90046-w","volume":"42","author":"HR Berthoud","year":"1993","unstructured":"Berthoud, H. R. & Powley, T. L. Characterization of vagal innervation to the rat celiac, suprarenal and mesenteric ganglia. J. Auton. Nerv. Syst. 42, 153\u2013169. https:\/\/doi.org\/10.1016\/0165-1838(93)90046-w (1993).","journal-title":"J. Auton. Nerv. Syst"},{"key":"18542_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/(SICI)1097-0029(19960901)35:1<80::AID-JEMT7>3.0.CO;2-W","volume":"35","author":"HR Berthoud","year":"1996","unstructured":"Berthoud, H. R. & Powley, T. L. Interaction between parasympathetic and sympathetic nerves in prevertebral ganglia: morphological evidence for vagal efferent innervation of ganglion cells in the rat. Microsc. Res. Tech. 35, 80\u201386. (1996).","journal-title":"Microsc. Res. Tech."},{"key":"18542_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.1209985","volume":"334","author":"M Rosas-Ballina","year":"2011","unstructured":"Rosas-Ballina, M. et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Sci. (New York N Y). 334, 98\u2013101. https:\/\/doi.org\/10.1126\/science.1209985 (2011).","journal-title":"Sci. (New York N Y)"},{"key":"18542_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12026-015-8718-1","volume":"63","author":"VA Pavlov","year":"2015","unstructured":"Pavlov, V. A. & Tracey, K. J. Neural circuitry and immunity. Immunol. Res. 63, 38\u201357. https:\/\/doi.org\/10.1007\/s12026-015-8718-1 (2015).","journal-title":"Immunol. Res."},{"key":"18542_CR40","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature01339","volume":"421","author":"H Wang","year":"2003","unstructured":"Wang, H. et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421, 384\u2013388. https:\/\/doi.org\/10.1038\/nature01339 (2003).","journal-title":"Nature"},{"key":"18542_CR41","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2119\/2008-00079.Parrish","volume":"14","author":"WR Parrish","year":"2008","unstructured":"Parrish, W. R. et al. Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol. Med. 14, 567\u2013574. https:\/\/doi.org\/10.2119\/2008-00079.Parrish (2008).","journal-title":"Mol. Med."},{"key":"18542_CR42","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/01.Ccm.0000259381.56526.96","volume":"35","author":"VA Pavlov","year":"2007","unstructured":"Pavlov, V. A. et al. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit. Care Med. 35, 1139\u20131144. https:\/\/doi.org\/10.1097\/01.Ccm.0000259381.56526.96 (2007).","journal-title":"Crit. Care Med."},{"key":"18542_CR43","doi-asserted-by":"publisher","unstructured":"Keever, K. R. et al. Cholinergic signaling via the \u03b17 nicotinic acetylcholine receptor regulates the migration of monocyte-derived macrophages during acute inflammation. J. Neuroinflamm. 21 https:\/\/doi.org\/10.1186\/s12974-023-03001-7 (2024).","DOI":"10.1186\/s12974-023-03001-7"},{"key":"18542_CR44","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00018-010-0525-1","volume":"68","author":"M Bencherif","year":"2011","unstructured":"Bencherif, M., Lippiello, P. M., Lucas, R. & Marrero, M. B. Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell. Mol. Life Sci. 68, 931\u2013949. https:\/\/doi.org\/10.1007\/s00018-010-0525-1 (2011).","journal-title":"Cell. Mol. Life Sci."},{"key":"18542_CR45","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/sj.bjp.0707264","volume":"151","author":"W De Jonge","year":"2007","unstructured":"De Jonge, W. & Ulloa, L. The alpha7 nicotinic acetylcholine receptor as a Pharmacological target for inflammation. Br. J. Pharmacol. 151, 915\u2013929 (2007).","journal-title":"Br. J. Pharmacol."},{"key":"18542_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s10020-020-00177-z","volume":"26","author":"RA Sitapara","year":"2020","unstructured":"Sitapara, R. A. et al. The \u03b17 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation. Mol. Med. 26, 63. https:\/\/doi.org\/10.1186\/s10020-020-00177-z (2020).","journal-title":"Mol. Med."},{"key":"18542_CR47","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1096\/fj.201600431R","volume":"31","author":"NM Pinheiro","year":"2017","unstructured":"Pinheiro, N. M. et al. Acute lung injury is reduced by the \u03b17nAChR agonist PNU-282987 through changes in the macrophage profile. FASEB J.: Official Publication Federation Am. Soc. Exp. Biol.. 31, 320\u2013332. https:\/\/doi.org\/10.1096\/fj.201600431R (2017).","journal-title":"FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology"},{"key":"18542_CR48","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1165\/rcmb.2006-0240OC","volume":"37","author":"X Su","year":"2007","unstructured":"Su, X. et al. Activation of the alpha7 nAChR reduces acid-induced acute lung injury in mice and rats. Am. J. Respir. Cell Mol. Biol. 37, 186\u2013192. https:\/\/doi.org\/10.1165\/rcmb.2006-0240OC (2007).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"18542_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/antiox10010135","volume":"10","author":"AG Gauthier","year":"2021","unstructured":"Gauthier, A. G. et al. The positive allosteric modulation of alpha7-Nicotinic cholinergic receptors by GAT107 increases bacterial lung clearance in hyperoxic mice by decreasing oxidative stress in macrophages. Antioxidants 10, 135 (2021).","journal-title":"Antioxidants"},{"key":"18542_CR50","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/jnc.15243","volume":"158","author":"CN Metz","year":"2021","unstructured":"Metz, C. N. & Pavlov, V. A. Treating disorders across the lifespan by modulating cholinergic signaling with galantamine. J. Neurochem. 158, 1359\u20131380. https:\/\/doi.org\/10.1111\/jnc.15243 (2021).","journal-title":"J. Neurochem."},{"key":"18542_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2008.06.011","volume":"23","author":"VA Pavlov","year":"2009","unstructured":"Pavlov, V. A. et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain. Behav. Immun. 23, 41\u201345. https:\/\/doi.org\/10.1016\/j.bbi.2008.06.011 (2009).","journal-title":"Brain. Behav. Immun."},{"key":"18542_CR52","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/mi.2013.52","volume":"7","author":"H Ji","year":"2014","unstructured":"Ji, H. et al. Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis. Mucosal Immunol. 7, 335\u2013347. https:\/\/doi.org\/10.1038\/mi.2013.52 (2014).","journal-title":"Mucosal Immunol."},{"key":"18542_CR53","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1002\/art.23807","volume":"58","author":"JM Waldburger","year":"2008","unstructured":"Waldburger, J. M. et al. Spinal p38 MAP kinase regulates peripheral cholinergic outflow. Arthritis Rheum. 58, 2919\u20132921. https:\/\/doi.org\/10.1002\/art.23807 (2008).","journal-title":"Arthritis Rheum."},{"key":"18542_CR54","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00362.2017","author":"GS Pham","year":"2018","unstructured":"Pham, G. S., Wang, L. A. & Mathis, K. W. Pharmacological potentiation of the efferent vagus nerve attenuates blood pressure and renal injury in a murine model of systemic lupus erythematosus. Am. J. Physiol. Regul. Integr. Comp. Physiol. https:\/\/doi.org\/10.1152\/ajpregu.00362.2017 (2018).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"18542_CR55","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2119\/molmed.2011.00083","volume":"17","author":"SK Satapathy","year":"2011","unstructured":"Satapathy, S. K. et al. Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice. Mol. Med. 17, 599\u2013606. https:\/\/doi.org\/10.2119\/molmed.2011.00083 (2011).","journal-title":"Mol. Med."},{"key":"18542_CR56","doi-asserted-by":"publisher","first-page":"107794","DOI":"10.1016\/j.pharmthera.2020.107794","volume":"222","author":"VA Pavlov","year":"2021","unstructured":"Pavlov, V. A. The evolving obesity challenge: targeting the vagus nerve and the inflammatory reflex in the response. Pharmacol. Ther. 222, 107794. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107794 (2021).","journal-title":"Pharmacol. Ther."},{"key":"18542_CR57","doi-asserted-by":"publisher","unstructured":"Consolim-Colombo, F. M. et al. Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial. JCI Insight. 2 https:\/\/doi.org\/10.1172\/jci.insight.93340 (2017).","DOI":"10.1172\/jci.insight.93340"},{"key":"18542_CR58","doi-asserted-by":"publisher","unstructured":"Sangaleti, C. T. et al. The cholinergic drug galantamine alleviates oxidative stress alongside Anti-inflammatory and Cardio-Metabolic effects in subjects with the metabolic syndrome in a randomized trial. Front. Immunol. 12 https:\/\/doi.org\/10.3389\/fimmu.2021.613979 (2021).","DOI":"10.3389\/fimmu.2021.613979"},{"key":"18542_CR59","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40635-020-00350-y","volume":"8","author":"L Chimenti","year":"2020","unstructured":"Chimenti, L. et al. Comparison of direct and indirect models of early induced acute lung injury. Intensive Care Med. Experimental. 8, 62. https:\/\/doi.org\/10.1186\/s40635-020-00350-y (2020).","journal-title":"Intensive Care Med. Experimental"},{"key":"18542_CR60","doi-asserted-by":"publisher","first-page":"L379","DOI":"10.1152\/ajplung.00010.2008","volume":"295","author":"G Matute-Bello","year":"2008","unstructured":"Matute-Bello, G., Frevert, C. W. & Martin, T. R. Animal models of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L379\u2013399. https:\/\/doi.org\/10.1152\/ajplung.00010.2008 (2008).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"18542_CR61","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ejcb.2011.11.004","volume":"91","author":"LK Reiss","year":"2012","unstructured":"Reiss, L. K., Uhlig, U. & Uhlig, S. Models and mechanisms of acute lung injury caused by direct insults. Eur. J. Cell Biol. 91, 590\u2013601. https:\/\/doi.org\/10.1016\/j.ejcb.2011.11.004 (2012).","journal-title":"Eur. J. Cell Biol."},{"key":"18542_CR62","doi-asserted-by":"publisher","unstructured":"Plataki, M. et al. Fatty acid synthase downregulation contributes to acute lung injury in murine diet-induced obesity. JCI Insight. 5 https:\/\/doi.org\/10.1172\/jci.insight.127823 (2019).","DOI":"10.1172\/jci.insight.127823"},{"key":"18542_CR63","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1242\/dmm.001677","volume":"2","author":"JA Bastarache","year":"2009","unstructured":"Bastarache, J. A. & Blackwell, T. S. Development of animal models for the acute respiratory distress syndrome. Dis. Models Mech. 2, 218\u2013223. https:\/\/doi.org\/10.1242\/dmm.001677 (2009).","journal-title":"Dis. Models Mech."},{"key":"18542_CR64","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1172\/jci29499","volume":"116","author":"A Zarbock","year":"2006","unstructured":"Zarbock, A., Singbartl, K. & Ley, K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J. Clin. Investig. 116, 3211\u20133219. https:\/\/doi.org\/10.1172\/jci29499 (2006).","journal-title":"J. Clin. Investig."},{"key":"18542_CR65","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/nm1494","volume":"12","author":"V Bhandari","year":"2006","unstructured":"Bhandari, V. et al. Hyperoxia causes angiopoietin 2\u2013mediated acute lung injury and necrotic cell death. Nat. Med. 12, 1286\u20131293. https:\/\/doi.org\/10.1038\/nm1494 (2006).","journal-title":"Nat. Med."},{"key":"18542_CR66","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","volume":"44","author":"G Matute-Bello","year":"2011","unstructured":"Matute-Bello, G. et al. An official American thoracic society workshop report: features and measurements of experimental acute lung injury in animals. Am. J. Respir. Cell Mol. Biol. 44, 725\u2013738. https:\/\/doi.org\/10.1165\/rcmb.2009-0210ST (2011).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"18542_CR67","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/1756-0500-7-233","volume":"7","author":"B Shrum","year":"2014","unstructured":"Shrum, B. et al. A robust scoring system to evaluate sepsis severity in an animal model. BMC Res. Notes. 7, 233. https:\/\/doi.org\/10.1186\/1756-0500-7-233 (2014).","journal-title":"BMC Res. Notes"},{"key":"18542_CR68","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore, K. W., de Waal Malefyt, R. & Coffman, R. L. O\u2019Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683\u2013765 (2001).","journal-title":"Annu. Rev. Immunol."},{"key":"18542_CR69","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1006\/cyto.1999.0655","volume":"12","author":"TP Shanley","year":"2000","unstructured":"Shanley, T. P. & Vasi, N. Denenberg, A regulation of chemokine expression by IL-10 in lung inflammation. Cytokine 12, 1054\u20131064. https:\/\/doi.org\/10.1006\/cyto.1999.0655 (2000).","journal-title":"Cytokine"},{"key":"18542_CR70","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1038\/s41598-019-42286-8","volume":"9","author":"J Zhao","year":"2019","unstructured":"Zhao, J. et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci. Rep. 9, 5790. https:\/\/doi.org\/10.1038\/s41598-019-42286-8 (2019).","journal-title":"Sci. Rep."},{"key":"18542_CR71","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1007\/s12035-017-0637-9","volume":"55","author":"B Becker","year":"2018","unstructured":"Becker, B. et al. Effect of intrastriatal 6-OHDA lesions on extrastriatal brain structures in the mouse. Mol. Neurobiol. 55, 4240\u20134252. https:\/\/doi.org\/10.1007\/s12035-017-0637-9 (2018).","journal-title":"Mol. Neurobiol."},{"key":"18542_CR72","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.neuron.2017.12.002","volume":"97","author":"C Madry","year":"2018","unstructured":"Madry, C. et al. Microglial ramification, surveillance, and Interleukin-1\u03b2 release are regulated by the Two-Pore domain K(+) channel THIK-1. Neuron 97, 299\u2013312e296. https:\/\/doi.org\/10.1016\/j.neuron.2017.12.002 (2018).","journal-title":"Neuron"},{"key":"18542_CR73","doi-asserted-by":"publisher","first-page":"100777","DOI":"10.1016\/j.cpsurg.2020.100777","volume":"57","author":"NT Mowery","year":"2020","unstructured":"Mowery, N. T., Terzian, W. T. H. & Nelson, A. C. Acute lung injury. Curr. Probl. Surg. 57, 100777. https:\/\/doi.org\/10.1016\/j.cpsurg.2020.100777 (2020).","journal-title":"Curr. Probl. Surg."},{"key":"18542_CR74","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1136\/thoraxjnl-2021-217031","volume":"76","author":"CF McGroder","year":"2021","unstructured":"McGroder, C. F. et al. Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length. Thorax 76, 1242\u20131245. https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217031 (2021).","journal-title":"Thorax"},{"key":"18542_CR75","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12974-015-0332-6","volume":"12","author":"IC Hoogland","year":"2015","unstructured":"Hoogland, I. C., Houbolt, C., van Westerloo, D. J., van Gool, W. A. & van de Beek, D. Systemic inflammation and microglial activation: systematic review of animal experiments. J. Neuroinflamm. 12, 114. https:\/\/doi.org\/10.1186\/s12974-015-0332-6 (2015).","journal-title":"J. Neuroinflamm."},{"key":"18542_CR76","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s42234-022-00101-2","volume":"8","author":"SP Palandira","year":"2022","unstructured":"Palandira, S. P. et al. A dual tracer [(11)C]PBR28 and [(18)F]FDG micropet evaluation of neuroinflammation and brain energy metabolism in murine endotoxemia. Bioelectron. Med. 8, 18. https:\/\/doi.org\/10.1186\/s42234-022-00101-2 (2022).","journal-title":"Bioelectron. Med."},{"key":"18542_CR77","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2119\/molmed.2014.00147","volume":"20","author":"HA Silverman","year":"2015","unstructured":"Silverman, H. A. et al. Brain region-specific alterations in the gene expression of cytokines, immune cell markers and cholinergic system components during peripheral endotoxin-induced inflammation. Mol. Med. 20, 601\u2013611. https:\/\/doi.org\/10.2119\/molmed.2014.00147 (2015).","journal-title":"Mol. Med."},{"key":"18542_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2018.11.006","author":"K Borst","year":"2018","unstructured":"Borst, K., Schwabenland, M. & Prinz, M. Microglia metabolism in health and disease. Neurochem. Int. https:\/\/doi.org\/10.1016\/j.neuint.2018.11.006 (2018).","journal-title":"Neurochem. Int."},{"key":"18542_CR79","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.immuni.2021.09.014","volume":"54","author":"K Borst","year":"2021","unstructured":"Borst, K., Dumas, A. A., Prinz, M. & Microglia Immune and non-immune functions. Immunity 54, 2194\u20132208. https:\/\/doi.org\/10.1016\/j.immuni.2021.09.014 (2021).","journal-title":"Immunity"},{"key":"18542_CR80","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1523\/jneurosci.4485-14.2015","volume":"35","author":"K Riazi","year":"2015","unstructured":"Riazi, K. et al. Microglia-Dependent alteration of glutamatergic synaptic transmission and plasticity in the hippocampus during peripheral inflammation. J. Neurosci. 35, 4942\u20134952. https:\/\/doi.org\/10.1523\/jneurosci.4485-14.2015 (2015).","journal-title":"J. Neurosci."},{"key":"18542_CR81","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12929-015-0157-8","volume":"22","author":"YH Ho","year":"2015","unstructured":"Ho, Y. H. et al. Peripheral inflammation increases seizure susceptibility via the induction of neuroinflammation and oxidative stress in the hippocampus. J. Biomed. Sci. 22, 46. https:\/\/doi.org\/10.1186\/s12929-015-0157-8 (2015).","journal-title":"J. Biomed. Sci."},{"key":"18542_CR82","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1538\/expanim.21-0120","volume":"71","author":"MZ Othman","year":"2022","unstructured":"Othman, M. Z., Hassan, Z. & Has, A. T. C. Morris water maze: a versatile and pertinent tool for assessing Spatial learning and memory. Exp. Anim. 71, 264\u2013280 (2022).","journal-title":"Exp. Anim."},{"key":"18542_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2832-2-1","volume":"2","author":"WE Reichman","year":"2003","unstructured":"Reichman, W. E. Current Pharmacologic options for patients with alzheimer\u2019s disease. Annals Gen. Hosp. Psychiatry. 2, 1 (2003).","journal-title":"Annals Gen. Hosp. Psychiatry"},{"key":"18542_CR84","first-page":"145","volume":"105","author":"JM Ellis","year":"2005","unstructured":"Ellis, J. M. Cholinesterase inhibitors in the treatment of dementia. J. Osteopath. Med. 105, 145\u2013158 (2005).","journal-title":"J. Osteopath. Med."},{"key":"18542_CR85","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0028-3908(91)90005-V","volume":"30","author":"U Bickel","year":"1991","unstructured":"Bickel, U., Thomsen, T., Fischer, J., Weber, W. & Kewitz, H. Galanthamine: pharmacokinetics, tissue distribution and cholinesterase Inhibition in brain of mice. Neuropharmacology 30, 447\u2013454 (1991).","journal-title":"Neuropharmacology"},{"key":"18542_CR86","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.neuron.2016.09.006","volume":"91","author":"EC Ballinger","year":"2016","unstructured":"Ballinger, E. C., Ananth, M., Talmage, D. A. & Role, L. W. Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline. Neuron 91, 1199\u20131218. https:\/\/doi.org\/10.1016\/j.neuron.2016.09.006 (2016).","journal-title":"Neuron"},{"key":"18542_CR87","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel, H. et al. The cholinergic system in the pathophysiology and treatment of alzheimer\u2019s disease. Brain: J. Neurol. 141, 1917\u20131933. https:\/\/doi.org\/10.1093\/brain\/awy132 (2018).","journal-title":"Brain: J. Neurol."},{"key":"18542_CR88","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1517\/17425251003592137","volume":"6","author":"D Prvulovic","year":"2010","unstructured":"Prvulovic, D., Hampel, H. & Pantel, J. Galantamine for alzheimer\u2019s disease. Expert Opin. Drug Metab. Toxicol. 6, 345\u2013354. https:\/\/doi.org\/10.1517\/17425251003592137 (2010).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"18542_CR89","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1001\/archneur.61.2.252","volume":"61","author":"MA Raskind","year":"2004","unstructured":"Raskind, M. A., Peskind, E. R., Truyen, L., Kershaw, P. & Damaraju, C. V. The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial. Arch. Neurol. 61, 252\u2013256. https:\/\/doi.org\/10.1001\/archneur.61.2.252 (2004).","journal-title":"Arch. Neurol."},{"key":"18542_CR90","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0306-4522(00)00180-9","volume":"99","author":"C Barnes","year":"2000","unstructured":"Barnes, C. et al. Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience 99, 17\u201323 (2000).","journal-title":"Neuroscience"},{"key":"18542_CR91","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.brainresbull.2004.11.002","volume":"64","author":"H Geerts","year":"2005","unstructured":"Geerts, H. Indicators of neuroprotection with galantamine. Brain Res. Bull. 64, 519\u2013524. https:\/\/doi.org\/10.1016\/j.brainresbull.2004.11.002 (2005).","journal-title":"Brain Res. Bull."},{"key":"18542_CR92","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/eurheartj\/eht182","volume":"34","author":"P Nordstrom","year":"2013","unstructured":"Nordstrom, P., Religa, D., Wimo, A., Winblad, B. & Eriksdotter, M. The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with alzheimer\u2019s disease. Eur. Heart J. 34, 2585\u20132591. https:\/\/doi.org\/10.1093\/eurheartj\/eht182 (2013).","journal-title":"Eur. Heart J."},{"key":"18542_CR93","doi-asserted-by":"publisher","first-page":"29266","DOI":"10.1038\/srep29266","volume":"6","author":"YT Lin","year":"2016","unstructured":"Lin, Y. T., Wu, P. H., Chen, C. S., Yang, Y. H. & Yang, Y. H. Association between acetylcholinesterase inhibitors and risk of stroke in patients with dementia. Sci. Rep. 6, 29266. https:\/\/doi.org\/10.1038\/srep29266 (2016).","journal-title":"Sci. Rep."},{"key":"18542_CR94","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jalz.2018.02.011","volume":"14","author":"ECK Tan","year":"2018","unstructured":"Tan, E. C. K. et al. Acetylcholinesterase inhibitors and risk of stroke and death in people with dementia. Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc. 14, 944\u2013951. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.011 (2018).","journal-title":"Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc."},{"key":"18542_CR95","doi-asserted-by":"publisher","first-page":"e000833","DOI":"10.1136\/bmjdrc-2019-000833","volume":"8","author":"J Secnik","year":"2020","unstructured":"Secnik, J. et al. Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~\u200923 000 patients from the Swedish dementia registry. BMJ Open. Diabetes Res. Care. 8, e000833. https:\/\/doi.org\/10.1136\/bmjdrc-2019-000833 (2020).","journal-title":"BMJ Open. Diabetes Res. Care"},{"key":"18542_CR96","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s10020-023-00746-y","volume":"29","author":"DA Thompson","year":"2023","unstructured":"Thompson, D. A. et al. Galantamine ameliorates experimental pancreatitis. Mol. Med. 29, 149. https:\/\/doi.org\/10.1186\/s10020-023-00746-y (2023).","journal-title":"Mol. Med."},{"key":"18542_CR97","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s10020-022-00571-9","volume":"28","author":"IT Mughrabi","year":"2022","unstructured":"Mughrabi, I. T. et al. Galantamine attenuates autoinflammation in a mouse model of Familial mediterranean fever. Mol. Med. 28, 148. https:\/\/doi.org\/10.1186\/s10020-022-00571-9 (2022).","journal-title":"Mol. Med."},{"key":"18542_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic. Clin. Pharm. 7, 27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703 (2016).","journal-title":"J. Basic. Clin. Pharm."},{"key":"18542_CR99","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fped.2014.00087","volume":"2","author":"DA Rossignol","year":"2014","unstructured":"Rossignol, D. A. & Frye, R. E. The use of medications approved for alzheimer\u2019s disease in autism spectrum disorder: a systematic review. Front. Pead. 2, 87. https:\/\/doi.org\/10.3389\/fped.2014.00087 (2014).","journal-title":"Front. Pead."},{"key":"18542_CR100","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1177\/0269881113508830","volume":"28","author":"A Ghaleiha","year":"2014","unstructured":"Ghaleiha, A. et al. Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial. J. Psychopharmacol. (Oxford, England). 28, 677\u2013685. https:\/\/doi.org\/10.1177\/0269881113508830 (2014).","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"18542_CR101","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/CCM.0000000000000040","volume":"42","author":"E Fan","year":"2014","unstructured":"Fan, E. et al. Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit. Care Med. 42, 849\u2013859 (2014).","journal-title":"Crit. Care Med."},{"key":"18542_CR102","doi-asserted-by":"publisher","first-page":"1313676","DOI":"10.1080\/20010001.2017.1313676","volume":"7","author":"J Morton","year":"2017","unstructured":"Morton, J. & Snider, T. A. Guidelines for collection and processing of lungs from aged mice for histological studies. Pathobiol Aging Age Relat. Dis. 7, 1313676. https:\/\/doi.org\/10.1080\/20010001.2017.1313676 (2017).","journal-title":"Pathobiol Aging Age Relat. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18542-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18542-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18542-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:25:31Z","timestamp":1758885931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18542-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18542"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18542-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"VAP and KJT have co-authored patents broadly related to the content of this paper. They have assigned their rights to the Feinstein Institutes for Medical Research. AF, SPP, SC, AT, FMC, CNM, MB, EHC, and SSC declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33217"}}